How many older adults receive drugs of questionable clinical benefit near the end of life? A cohort study

BACKGROUND: The high burden of disease-oriented drugs among older adults with limited life expectancy raises important questions about the potential futility of care. AIM: To describe the use of drugs of questionable clinical benefit during the last 3 months of life of older adults who died from lif...

Descripción completa

Detalles Bibliográficos
Autores principales: Morin, Lucas, Wastesson, Jonas W, Laroche, Marie-Laure, Fastbom, Johan, Johnell, Kristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691599/
https://www.ncbi.nlm.nih.gov/pubmed/31172885
http://dx.doi.org/10.1177/0269216319854013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691599/
https://www.ncbi.nlm.nih.gov/pubmed/31172885
http://dx.doi.org/10.1177/0269216319854013

Ejemplares similares